These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 8788437)
21. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors. Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319 [TBL] [Abstract][Full Text] [Related]
22. NK2 receptors mediate tachykinin-induced contractions of rat uterus during the oestrous cycle. Moodley N; Lau WA; Pennefather JN; Story ME; Fisher L Eur J Pharmacol; 1999 Jul; 376(1-2):53-60. PubMed ID: 10440089 [TBL] [Abstract][Full Text] [Related]
23. Human tachykinin NK2 receptor: a comparative study of the colon and urinary bladder. Warner FJ; Miller RC; Burcher E Clin Exp Pharmacol Physiol; 2003 Sep; 30(9):632-9. PubMed ID: 12940880 [TBL] [Abstract][Full Text] [Related]
24. Effect of nepadutant at tachykinin NK(2) receptors in human intestine and urinary bladder. Patacchini R; Giuliani S; Turini A; Navarra G; Maggi CA Eur J Pharmacol; 2000 Jun; 398(3):389-97. PubMed ID: 10862829 [TBL] [Abstract][Full Text] [Related]
26. Non-peptide angiotensin receptor antagonists bind to tachykinin NK3 receptors of rat and guinea pig brain. Chrétien L; Guillemette G; Regoli D Eur J Pharmacol; 1994 Apr; 256(1):73-8. PubMed ID: 7517891 [TBL] [Abstract][Full Text] [Related]
27. Characterization of tachykinin NK2 receptor on dog proximal colon. Antagonism by MEN 10,627 and SR 48,968. Parlani M; Conte B; Cirillo R; Manzini S Eur J Pharmacol; 1996 Dec; 318(2-3):419-24. PubMed ID: 9016933 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors. Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556 [TBL] [Abstract][Full Text] [Related]
29. Role of prostanoids in the contraction induced by a tachykinin NK2 receptor agonist in the hamster urinary bladder. Tramontana M; Catalioto RM; Lecci A; Maggi CA Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):452-9. PubMed ID: 10763862 [TBL] [Abstract][Full Text] [Related]
30. Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801. Beaujouan JC; Saffroy M; Torrens Y; Glowinski J Eur J Pharmacol; 1997 Jan; 319(2-3):307-16. PubMed ID: 9042606 [TBL] [Abstract][Full Text] [Related]
31. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder. Hall JM; Flowers JM; Morton IK Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072 [TBL] [Abstract][Full Text] [Related]
32. Depressed contractile responses to neurokinin A in idiopathic but not neurogenic overactive human detrusor muscle. Sellers DJ; Chapple CR; W Hay DP; Chess-Williams R Eur Urol; 2006 Mar; 49(3):510-8. PubMed ID: 16420969 [TBL] [Abstract][Full Text] [Related]
33. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips. Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807 [TBL] [Abstract][Full Text] [Related]
34. Activity of SR 142801 at peripheral tachykinin receptors. Patacchini R; Barthò L; Holzer P; Maggi CA Eur J Pharmacol; 1995 May; 278(1):17-25. PubMed ID: 7545122 [TBL] [Abstract][Full Text] [Related]
36. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord. Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986 [TBL] [Abstract][Full Text] [Related]
37. Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices. Seabrook GR; Bowery BJ; Hill RG Eur J Pharmacol; 1995 Jan; 273(1-2):113-9. PubMed ID: 7537676 [TBL] [Abstract][Full Text] [Related]
38. Tachykinin NK1 receptor subtypes in the rat urinary bladder. Meini S; Patacchini R; Maggi CA Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327 [TBL] [Abstract][Full Text] [Related]
39. Tachykinin NK2 receptors: characterization in the rat small intestine by the use of a peptide agonist and a nonpeptide antagonist as radioligands. Renzetti AR; Criscuoli M; Maggi CA Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):139-44. PubMed ID: 9228201 [TBL] [Abstract][Full Text] [Related]
40. Multifaceted approach to determine the antagonist molecular mechanism and interaction of ibodutant ([1-(2-phenyl-1R-[[1-(tetrahydropyran-4-ylmethyl)-piperidin-4-ylmethyl]-carbamoyl]-ethylcarbamoyl)-cyclopentyl]-amide) at the human tachykinin NK2 receptor. Meini S; Bellucci F; Catalani C; Cucchi P; Giolitti A; Santicioli P; Giuliani S J Pharmacol Exp Ther; 2009 May; 329(2):486-95. PubMed ID: 19218528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]